Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
Aiden Haghikia(Ruhr University Bochum), Calliope A. Dendrou(University of Oxford), Ruth Schneider(St. Josef-Hospital), Thomas Grüter(Ruhr University Bochum), Thomas Postert(St. Vincenz-Krankenhaus Limburg), Mike Matzke(University Hospital Magdeburg), Heike Stephanik(University Hospital Magdeburg), Lars Fugger(John Radcliffe Hospital), Ralf Gold(Ruhr University Bochum)
Cited by 65Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis